In Brief Elisabeth Heath, of Karmanos, receives the Michigan Cancer Consortium’s inaugural Champion Award November 11, 2016Vol.42 No.42
In Brief Craig Reynolds to retire as as director of the NCI Office of Scientific Operations at Frederick November 11, 2016Vol.42 No.42
Drugs & Targets Hopkins and BMS announce five-year collaboration to study resistance to checkpoint blockers and develop combination immunotherapies. November 11, 2016Vol.42 No.42
In Brief William Cance joins University of Arizona Cancer Center as deputy director November 11, 2016Vol.42 No.42
In Brief Charles Drake joins NY-Presbyterian/Columbia as director of genitourinary oncology. associate director at the Columbia Cancer Center, co-director immunotherapy program. November 11, 2016Vol.42 No.42
Drugs & Targets Amgen and Janssen Biotech to evaluate combination of Amgen’s Kyprolis and Janssen’s Darzalex in multiple clinical studies in multiple myeloma November 11, 2016Vol.42 No.42
In Brief IU School of Nursing establishes Champion Center for Cancer Control Research, named after Distinguished Professor Victoria Champion. November 11, 2016Vol.42 No.42
Funding Opportunities SU2C makes $7.5 million in grants available to early-career scientists focusing on immuno-oncology November 11, 2016Vol.42 No.42